#healthday {color:#000000;}#healthday h2 {margin:0px;padding:0px;font-weight:bold;}#healthday a {margin:0px;padding:0px;font-decoration:underline;}#healthday .image {float:left;padding-right:10px;padding-bottom:10px;border:0px;}#healthday .blurb{display:block;}
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More